Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer

Lin, Jia; Yu, Y; Shigdar, Sarah; Fang, D; Rong Du, J; Wei, M; Danks, A; Liu, K; Duan, Wei

duan-enhancedantitumor-2012.pdf (1.95 MB)

Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer

journal contribution

posted on 2012-01-01, 00:00 authored by Jia Lin, Y Yu, Sarah ShigdarSarah Shigdar, D Fang, J Rong Du, M Wei, A Danks, K Liu, Wei DuanWei Duan

Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer

History

Journal

Plos One

Volume

7

Issue

11

Pagination

1 - 10

Publisher

Public Library of Science

Location

San Francisco, Calif.

ISSN

1932-6203

Language

eng

Notes

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication classification

C Journal article; C1.1 Refereed article in a scholarly journal

Copyright notice

2012, Lin et al.

Usage metrics

Keywords

Science & Technology Multidisciplinary Sciences Science & Technology - Other Topics CO-ENCAPSULATING DOXORUBICIN PROMOTES CELL-ADHESION MULTIDRUG-RESISTANCE DRUG-DELIVERY COLON-CANCER INTRACELLULAR DELIVERY INDUCED CARDIOMYOPATHY EXTRACELLULAR-MATRIX MONOCLONAL-ANTIBODY POLYETHYLENE-GLYCOL

Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer

History

Journal

Volume

Issue

Pagination

Publisher

Location

ISSN

Language

Notes

Publication classification

Copyright notice

Usage metrics

Categories

Keywords

Licence

Exports